Folic Acid
Active ingredient · 2 therapeutic classes
Sold as FOLVITE
- Drug class
- Folic Acid and Derivatives
- Availability
- Prescription only
- Routes
- Oral, Intramuscular
- Markets covered
- 3
- Products on record
- 43
- FDA reports (12 mo)
- 10,768
Overview
Plain-language summary, compiled from the cited regulatory records
Folic acid is a B vitamin that plays a crucial role in cell growth and development [1]. It belongs to the drug class of Folic Acid and Derivatives [1].
Folic acid is approved for treating certain types of anemia, specifically megaloblastic anemias caused by a folic acid deficiency. This includes anemias seen in conditions like tropical or nontropical sprue. It is also used for anemias that arise from nutritional deficiencies, pregnancy, infancy, or childhood [1].
In the market, folic acid is available under various brand names. There were 10,768 adverse event reports for folic acid in the past 12 months [2]. The most frequently reported reasons for these reports included off-label use, fatigue, pain, the drug being ineffective, and joint pain (arthralgia) [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 29 | May 22, 2026 |
| US United States | FDA | 10 | December 26, 2025 |
| CA Canada | Health Canada | 4 | August 15, 2025 |
GBUnited Kingdom· MHRA
29 products
Uses
The prophylaxis of iron and folic acid deficiencies during pregnancy
How to take
USUnited States· FDA
10 products
Uses
INDICATIONS AND USAGE
Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
How to take
CACanada· Health Canada
4 products
Uses
FOLIC ACID (folic acid) is indicated for: The prevention and treatment of folate deficiency due to inadequate dietary intake, absorption or utilization or increased excretion or need as in tropical sprue (not in all forms of sprue), chronic haemodialysis, chronic haemolytic anaemia, nutritional megaloblastic anaemia, megaloblastic anaemia of pregnancy, infancy, and childhood, and megaloblastic anaemia associated with primary liver disease, alcoholism with cirrhosis, or associated with anticonvulsant therapy.
Women who are planning pregnancy or are pregnant and have had a previous pregnancy affected by a neural tube defect (NTD), who have a family history of neural tube defects, have diabetes or malabsorption disorders, who are taking folic acid antagonists or anticonvulsant drugs.
FOLIC ACID should only be used in conditions in which folate deficiency has been confirmed; specific indicators are: the low serum or plasma folate levels [initial], red cell folate level [cannot distinguish between folate deficiency and cobalamin deficiency and it remains unaffected by sudden changes in folate intake since it reflects the folate status over the lifespan of a red blood cell [120 days] an increase in homocysteine level [often precedes the decrease in the serum folate levels but its less specific indicator.
Drug interactions
Known interactions involving Folic Acid. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 420. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL002400105 · revised April 10, 2026
- [2]FDA DailyMed · 03b0aee4-804a-de… · revised December 26, 2025 [PDF]
- [3]Health Canada (DPD) · 00426849 · revised March 22, 2025
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.